Fluidigm said today that Research Instruments/RI Technologies will distribute its products in Singapore and Thailand.

Under the agreement, Research Instruments will sell Fluidigm's complete portfolio of BioMark HD, EP1, and Access Array systems; the complete lineup of Dynamic Array, Digital Array, and Access Array integrated fluidic chips for real-time PCR, digital PCR, single-cell gene expression, sample prep for next-gen sequencing, and genotyping; and Fluidigm's new DELTAgene and SNPtype assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.